BackCytek BioSciences Overview
Cytek BioSciences Inc

Cytek BioSciences Target Price

See Cytek BioSciences's analyst price targets ($5.5) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$5.84

Average Target Price

$5.505.8% downside

2 analysts in the last 4 months

High: $6 | Low: $5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-10-23Stephens$62.7% upsideOpen
2026-08-07Morgan Stanley$514.4% downsideOpen
2026-05-13Stephens$4.7518.7% downsideOpen
2026-05-12Morgan Stanley$5.55.8% downsideOpen
2025-12-01Morgan Stanley$62.7% upsideOpen
2025-03-04Piper Sandler$837% upsideOpen
2025-02-02Goldman SachsMatthew Sykes$5.2510.1% downsideOpen
2024-05-13Piper SandlerDave Westenberg$8.545.5% upsideOpen
2022-08-17Piper SandlerDavid Westenberg$16174% upsideOpen
2022-05-15Piper SandlerDavid Westenberg$12105.5% upsideOpen

Cytek BioSciences (CTKB) FAQ

Cytek BioSciences (CTKB) currently reports a target price of $5.5. Use the charts on this page to explore Cytek BioSciences's target price history and peer comparisons.

Analysts' average 12-month price target for Cytek BioSciences is $5.5, about 5.8% downside from the current share price of $5.84. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $5.5, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cytek BioSciences, and consider following CTKB for alerts when major investors trade the stock.

Cytek BioSciences is classified in the Healthcare sector. On target price, it currently shows $5.5. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CTKB with unrelated industries.